Current developments in treatment of bone metastases. Radiotherapy, surgical procedures, and bisphosphonates;Aktuelle entwicklungen in der therapie von knochenmetastasen. Strahlentherapie, operative verfahren, bisphosphonate

Onkologe

Volumn 10, Issue 5, 2004, Pages 492-503

  Bremer, M ^a   Tunn, P U ^b   Peest, D ^a   Karstens, J H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bisphosphonates; Bone metastases; Multimodal therapy; Radiotherapy; Spinal cord compression; Surgery

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURGERY; HUMAN; MULTIMODALITY CANCER THERAPY; PATHOLOGIC FRACTURE; PROGNOSIS; PROPHYLAXIS; QUALITY OF LIFE; SPINAL CORD COMPRESSION; SURVIVAL;

EID: 2942718801     PISSN: 09478965     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00761-004-0705-4     Document Type: Article

References (50)

1. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer (2000) J Clin Oncol 18:1378-1391
2. Belch AR, Bergsagel DE, Wilson K, O'Reilly S, Wilson J, Sutton O, Pater J, Johnston D, Zee B (1991) Effect of daily etidronate on the osteolysis of multiple myeloma. J Clin Oncol 9:1397-1402
3. Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, Biermann JS (2002) American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 20:3719-3736
4. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffernan M, Seaman J, Knight RD (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med 334:488-493
5. Blitzer PH (1985) Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 55:1468-1472
6. Body JJ, Kanis J, Diel I, Bergstrom B (2003) Risk reductions in metastatic breast cancer: multivariate Poisson regression analyses of oral and i.v. ibandronate. Proc ASCO 22: Abstr.#184
7. Bremer M, Rades D, Blach M, Krenkel B, Karstens JH (1999) Effectiveness of hypofractionated radiotherapy in painful bone metastases. Strahlenther Onkol 17S:382-386
8. Chow E,Wu JSY, Hoskin P, Coia LR, Bentzen SM, Blitzer PH (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 2002 64:275-280
9. Dearnaley DP, Sydes MR, Mason MD, Stott M, Powell CS, Robinson AC, Thompson PM, Moffat LE, Naylor SL, Parmar MK (2003) A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial). J Natl Cancer Inst 95:1300-1311
10. Djulbegovic B, Wheatley K, Ross J, Clark O, Bos G, Goldschmidt H, Cremer F, Alsina M, Glasmacher A (2003) Bisphosphonates in multiple myeloma. (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software
11. Dominkus M, Krepler P, Schwameis E, Kotz R (1998) Operative Therapie ron Wirbelsäulenmetastasen. Orthopäde 27:282-286
12. Enright K, Clemons M, Chow E (2004) Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience. Support Care Cancer 12:48-52
13. Falkmer U, Järhult J, Wersill P, Cavallin-Ståhl E (2003) A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol 42:620-633
14. Fourney DR, Schomer DF, Nader R et al. (2003) Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 98 (1 Suppl):21-30
15. Friedl W, Mieck U, Fritz Th (1992) Chirurgische Therapie von Knochenmetastasen der oberen und unteren Extremität. Chirurg 62:897-911
16. Hartsell WE, Scott C, Bruner DW, Scarantino CW, Ivker R, Roach M, Suh J, Demas W, Movsas B, Petersen I, Konski A (2003) Phase III trial of 8 Gy in 1 fraction vs. 30 Gy in 10 fractions for palliation of painful bone metastases: preliminary results of RTOG 97-14. Int J Radiat Oncol Biol Phys 57 (2 Suppl):S124
17. Helmberger T, Bohndoff K, Hierholzer J, Nöldge G, Vorwerk D (2003) Leitlinien der Deutschen Röntgengesellschaft zur Vertebroplastie. Radiologe 43:703-708
18. Helweg-Larsen S, Sorensen PS, Kreiner S (2000) Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 46:1163-1169
19. Hillner BE, Ingle JN, Chelbowski RT, Gralow J, Yee GC, Janjan NA, Cauley JA, Blumenstein BA, Albain KS, Lipton A, Brown S (2003) American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21:4042-4057
20. Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, Wheeler H, Simeone JF, Seaman JJ, Knight RD, Heffeman M, Mellars K, Reitsma DJ (1998) Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol 16:2038-2044
21. Hoskin PJ (2003) Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treat Rev 29:321-327
22. Hoskin PJ, Yarnold JR, Roos DR, Bentzen S, on behalf of the participants of the second workshop on palliative radiotherapy and symptom control (2001) Consensus statement: Radiotherapy for bone metastases. Clin Oncol 13:88-90
23. Koswig S, Budach V (1999) Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy): a prospective study. Strahlenther Onkol 175:500-508
24. Lahtinen R, Laakso M, Palva I, Virkkunen P, Elomaa I (1992) Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group. Lancet 340:1049-1052
25. Lipton A, Theriault RL, Hortobagyi GN, Simeone J, Knight RD, Mellars K, Reitsma DJ, Heffernan M, Seaman JJ (2000) Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 88:1082-1090
26. Maranzano E, Latini P (1995) Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys 32:9S9-996
27. McCloskey EV, MacLennan IC, Drayson MT, Chapman C, Dunn J, Kanis JA (1998) A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults. Br J Haematol 100:317-325
28. McQuay HJ, Collins SL, Carroll D, Moore RA (2000) Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev 2:CD001793
29. Menssen HD, Sakalova A, Fontana A, Herrmann Z, Boewer C, Facon T, Lichinitser MR, Singer CR, Euller-Ziegler L, Wetterwald M, Fiere D, Hrubisko M, Thiel E, Delmas PD (2002) Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma. J Clin Oncol 20:2353-2359
30. Merlini G, Parrinello GA, Piccinini L, Crema F, Fiorentini ML, Riccardi A, Pavesi F, Novazzi F, Silingardi V, Ascari E (1990) Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. Hematol Oncol 23-30
31. Mirels H (1989) Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathological fractures. Clin Orthop 249:256-265
32. Patchell R (2003) A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Proc ASCO 22: Abstr.#2
33. Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J, Ashley S (1993) Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 11:59-65
34. Pavlakis N, Stockler M (2004) Bisphosphonates for breast cancer. (Cochrane Review). In: The Cochrane Library, Issue 1, Chichester, U.K: John Wiley & Sons, Ltd
35. Prinzipien der modernen Strahlentherapie (Radioonkologe) (2002). In: Qualitätsicherung in der Onkologie. Kurzgefasste Interdisziplinäre Leitlinien der Deutschen Krebsgesellschaft e.V. Zuckschwerdt, München Bern Wien New York, S 27-45
36. Rades D, Heidenreich F, Bremer M, Karstens JH (2001) Time of developing motor deficits before radiotherapy as a new and relevant prognostic factor in metastatic spinal cord compression: final results ofa retrospective analysis. Eur Neurol 45:266-269
37. Ratanatharathorn V, Powers WE, Moss WT, Perez CA (1999) Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys 44:1-18
38. Ratanatharathorn V, Powers WE, Temple HT (2004) Palliation of bone metastases. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK (eds) Principles and practice of radiation oncology. 4th ed. Lippincott, Philadelphia Baltimore New York, 2385-2404
39. Roos DE, O'Brien PC, Smith JG, Spry NA, Hoskin PJ, Burmeister BH, Turner SL, Bernshaw DMA (2000) role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-tasman radiation oncology group, TROG 96.05). Int J Radiat Oncol Biol Phys 46:975-981
40. Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein M, Coleman RE, Reitsma DJ, Seaman JJ, Chen BL, Ambros Y (2001) Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J 7:377-387
41. Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, de Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman JJ (2003) Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial. The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 21:3150-3157
42. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B (2002) Zoledronic Acid Prostate Cancer Study Group: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 94:1458-68
43. Sabo D, Bernd L (1998) Operative Therapie von Skelettmetastasen der Extremitäten. Orthopäde 27:274-281
44. Sarzier JS, Evans AJ (2003) Intrathecal injection of contrast medium to prevent PMMA leakage during percutaneous vertebroplasty. Am J Neuroradiol 24:1001-1002
45. Small EJ, Smith MR, Seaman JJ, Petrone S, Kowalski MO (2003) Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer. J Clin Oncol 21:4277-4284
46. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Warlam-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E, Leer J, van Mierlo T (1999) The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol S2:101-109
47. Theriault RL, Lipton A, Hortobagyi GN, Leff R, Gluck S, Stewart JF, Costello S, Kennedy I, Simeone J, Seaman JJ, Knight RD, Mellars K, Heffernan M, Reitsma DJ (1999) Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group. J Clin Oncol 17:846-854
48. Tunn PU, Schmidt-Peter P, Schlag PM (2000) Operative Behandlung von sekundären Knochentumoren. Onkologe 6:738-746
49. Windhager R, Ritschl P, Rokus U, Kickinger W, Braun O, Kotz R (1989) Die Rezidivfreudigkeit von intra- und extralesional operierten Metastasen langer Röhrenknochen. Z Orthop 127:402-405
50. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T (2003) Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55:594-605